BAJAJ BROKING

Notification close image
No new Notification messages
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

530233

AUROLAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

AURO LABORATORIES LTD. Share Price Update

As of the latest trading session, AURO LABORATORIES LTD. share price is currently at ₹ 240, which is up by ₹ 5.39 from its previous closing. Today, the stock has fluctuated between ₹ 226.05 and ₹ 248.00. Over the past year, AURO LABORATORIES LTD. has achieved a return of 23.92 %. In the last month alone, the return has been -7.64 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

AURO LABORATORIES LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    149.50

  • P/E Ratio (TTM)

    214.11

  • Beta

    0.69

  • Book Value / share

    68.94

  • Return on equity

    4.33%

  • EPS (TTM)

    1.12

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -0.11

info icon alternate text

AURO LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 2.77
Operating Expense 3.30
Net Profit -0.11
Net Profit Margin (%) -3.97
Earnings Per Share (EPS) -0.17
EBITDA 0.44
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 7.40
Operating Expense 7.17
Net Profit 0.39
Net Profit Margin (%) 5.27
Earnings Per Share (EPS) 0.63
EBITDA 0.94
Effective Tax Rate (%) -11.42
Particulars DEC 2024 (Values in Cr)
Revenue 3.05
Operating Expense 3.13
Net Profit 0.05
Net Profit Margin (%) 1.63
Earnings Per Share (EPS) 0.08
EBITDA 0.59
Effective Tax Rate (%) 28.57
Particulars SEP 2024 (Values in Cr)
Revenue 3.10
Operating Expense 2.92
Net Profit 0.36
Net Profit Margin (%) 11.61
Earnings Per Share (EPS) 0.57
EBITDA 1.03
Effective Tax Rate (%) 25.00
Particulars JUN 2024 (Values in Cr)
Revenue 5.72
Operating Expense 4.92
Net Profit 0.75
Net Profit Margin (%) 13.11
Earnings Per Share (EPS) 1.21
EBITDA 1.53
Effective Tax Rate (%) 24.75
Particulars MAR 2025 (Values in Cr)
Revenue 19.40
Operating Expense 18.17
Net Profit 1.84
Net Profit Margin (%) 9.48
Earnings Per Share (EPS) 2.95
EBITDA 4.06
Effective Tax Rate (%) 2.12
Particulars MAR 2024 (Values in Cr)
Revenue 53.64
Operating Expense 44.80
Net Profit 7.79
Net Profit Margin (%) 14.52
Earnings Per Share (EPS) 12.50
EBITDA 12.18
Effective Tax Rate (%) 24.63
Particulars MAR 2023 (Values in Cr)
Revenue 52.89
Operating Expense 50.39
Net Profit 2.44
Net Profit Margin (%) 4.61
Earnings Per Share (EPS) 3.92
EBITDA 5.33
Effective Tax Rate (%) 28.98
Particulars MAR 2022 (Values in Cr)
Revenue 50.87
Operating Expense 48.08
Net Profit 2.84
Net Profit Margin (%) 5.58
Earnings Per Share (EPS) 4.56
EBITDA 5.72
Effective Tax Rate (%) 26.61
Particulars MAR 2021 (Values in Cr)
Revenue 54.25
Operating Expense 44.51
Net Profit 7.18
Net Profit Margin (%) 13.23
Earnings Per Share (EPS) 11.52
EBITDA 12.01
Effective Tax Rate (%) 31.68
Particulars MAR 2025 (Values in Cr)
Book Value / Share 68.94
ROE % 4.33
ROCE % 3.79
Total Debt to Total Equity 0.81
EBITDA Margin 20.93
Particulars MAR 2024 (Values in Cr)
Book Value / Share 67.32
ROE % 20.46
ROCE % 20.37
Total Debt to Total Equity 0.43
EBITDA Margin 22.71
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.87
ROE % 7.43
ROCE % 9.89
Total Debt to Total Equity 0.31
EBITDA Margin 10.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share 50.58
ROE % 9.45
ROCE % 12.20
Total Debt to Total Equity 0.28
EBITDA Margin 11.24
Particulars MAR 2021 (Values in Cr)
Book Value / Share 45.86
ROE % 28.67
ROCE % 38.90
Total Debt to Total Equity 0.13
EBITDA Margin 22.12
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.62
Total Assets 99.09
Total Liabilities 99.09
Total Equity 42.96
Share Outstanding 6232500
Price to Book Ratio 3.34
Return on Assets (%) 1.85
Return on Capital (%) 2.15
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.64
Total Assets 85.73
Total Liabilities 85.73
Total Equity 41.95
Share Outstanding 6232500
Price to Book Ratio 2.39
Return on Assets (%) 9.08
Return on Capital (%) 11.42
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.41
Total Assets 55.99
Total Liabilities 55.99
Total Equity 34.20
Share Outstanding 6232500
Price to Book Ratio 1.00
Return on Assets (%) 4.36
Return on Capital (%) 6.01
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.39
Total Assets 54.96
Total Liabilities 54.96
Total Equity 31.52
Share Outstanding 6232500
Price to Book Ratio 1.98
Return on Assets (%) 5.17
Return on Capital (%) 6.28
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 14.53
Total Assets 41.89
Total Liabilities 41.89
Total Equity 28.58
Share Outstanding 6232500
Price to Book Ratio 1.77
Return on Assets (%) 17.13
Return on Capital (%) 22.7
Particulars MAR 2025 (Values in Cr)
Net Income 1.88
Cash from Operations 5.74
Cash from Investing -24.45
Cash from Financing 17.68
Net change in Cash -1.01
Free Cash Flow 29.54
Particulars MAR 2024 (Values in Cr)
Net Income 10.34
Cash from Operations 18.80
Cash from Investing -38.67
Cash from Financing 19.09
Net change in Cash -0.76
Free Cash Flow 54.44
Particulars MAR 2023 (Values in Cr)
Net Income 3.44
Cash from Operations 3.28
Cash from Investing -5.08
Cash from Financing -8.17
Net change in Cash -9.97
Free Cash Flow 7.35
Particulars MAR 2022 (Values in Cr)
Net Income 3.87
Cash from Operations -6.59
Cash from Investing -5.34
Cash from Financing 9.79
Net change in Cash -2.14
Free Cash Flow -1.98
Particulars MAR 2021 (Values in Cr)
Net Income 10.50
Cash from Operations 12.81
Cash from Investing -3.50
Cash from Financing -0.45
Net change in Cash 8.85
Free Cash Flow 13.19
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.51 12.86 1.72 241.47 30.00 / 68.00
BLISS GVS PHARMA LTD 152.50 15.10 1.53 1609.97 105.05 / 190.65
CIPLA LTD 1573.80 23.57 4.07 127124.34 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 363.70 10.24 2.95 1070.41 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2774.95 49.64 24.09 47009.33 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.89 17.33 5.03 244.38 30.00 / 68.85
AMRUTAJAN HEALTH LTD 750.80 39.81 6.64 2170.61 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9065.70 107.17 29.42 22664.25 6222.35 / 10653.05
BLISS GVS PHARMA LTD 153.20 22.90 1.52 1617.36 105.05 / 190.65

AURO LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
239.80 2.21 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 233.60
  • 26 Days 240.80
  • 10 Days 232.50
  • 50 Days 249.00
  • 12 Days 233.10
  • 100 Days 251.50
  • 20 Days 237.50
  • 200 Days 243.00
234.53 PIVOT

First Support

229.07

First Resistance

240.07

Second Support

223.53

Second Resistance

245.53

Third Support

218.07

Third Resistance

251.07

RSI

48.91

ADX

30.90

MACD

-7.69

Williams % R

-20.42

Commodity Channel Index (CCI)

5.81

Date

2025-09-12

Week

3021.00

Same Day

620.00

Month

5819.00

1 Year

0.69

3 Year

0.45

Over 1 Month

-7.64%

down

Over 1 Year

23.92%

down

Over 3 Months

-12.51%

down

Over 3 Years

41.55%

down

Over 6 Months

1.67%

down

Over 5 Years

32.96%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

AURO LABORATORIES LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
47.81%
Promoter Holdings
52.17%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Auro Impex Private Ltd 1168781.0 (18.75%) Shareholding of Promoter and Promoter Group
Sharat Deorah 1165800.0 (18.71%) Shareholding of Promoter and Promoter Group
Siddhartha Deorah 441650.0 (7.09%) Shareholding of Promoter and Promoter Group
Samridhi Deorah 241191.0 (3.87%) Shareholding of Promoter and Promoter Group
Sharat Deorah Huf 229029.0 (3.67%) Shareholding of Promoter and Promoter Group
Kirtilaben Jayantilal Mehta 195000.0 (3.13%) Public Shareholding
Shikha Lohia 96126.0 (1.54%) Public Shareholding
Ravi Parimal Shah 90571.0 (1.45%) Public Shareholding
Ushma Gautam Doshi 85000.0 (1.36%) Public Shareholding
Siddhartha Deorah Huf 5456.0 (0.09%) Shareholding of Promoter and Promoter Group
Suman Bhuwania 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

AURO LABORATORIES LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

AURO LABORATORIES LTD. Share Price

Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API). Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes. The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra. The facility has all the required certifications from Indian authorities and European registration organization

Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards. Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA.

The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments. Currently, it manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment. Additionally, it also undertake Toll/Custom Manufacturing for API's and Intermediates on contract basis. The manufacturing facility operates are per cGMP norms and has an installed capacity in excess of 500 Tonnes per annum.

Auro laboratories has made its presence felt in international markets with a bulk of it production being exported to South East Asia, Middle East and several European Countries. Some of the countries the company exports to are Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom.

The Company received ISO 9001:2000 and WHO - cGMPs certification. It also received CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) in September 2006.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Auro Laboratories Ltd?

Answer Field

Auro Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 239.80 as on Sep 12 2025 03:29 PM.

What is the Market Cap of Auro Laboratories Ltd Share?

Answer Field

The market cap of Auro Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 149.50 as on Sep 12 2025 03:29 PM.

What is the 52 Week High and Low of Auro Laboratories Ltd?

Answer Field

The 52 Week High and Low of Auro Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 303.00 and ₹ 170.00.

What is 1 year return for Auro Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 23.92%.

What is the P/E Ratio of Auro Laboratories Ltd Share?

Answer Field

As on Sep 12 2025 03:29 PM the price-to-earnings (PE) ratio for Auro Laboratories Ltd share is 214.11.

What is the PB ratio of Auro Laboratories Ltd Share?

Answer Field

As on Sep 12 2025 03:29 PM, the price-to-book (PB) ratio for Auro Laboratories Ltd share is 68.94.

How to Buy Auro Laboratories Ltd Share?

Answer Field

You can trade in Auro Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Auro Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Auro Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Auro Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91